Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

References for PMC Articles for PubMed (Select 10318916)

1.

Inhibition of beta-catenin-mediated transactivation by cadherin derivatives.

Sadot E, Simcha I, Shtutman M, Ben-Ze'ev A, Geiger B.

Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15339-44.

2.

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.

Diehl JA, Cheng M, Roussel MF, Sherr CJ.

Genes Dev. 1998 Nov 15;12(22):3499-511.

3.

Differential molecular interactions of beta-catenin and plakoglobin in adhesion, signaling and cancer.

Ben-Ze'ev A, Geiger B.

Curr Opin Cell Biol. 1998 Oct;10(5):629-39. Review.

PMID:
9818174
4.

The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors.

Roose J, Molenaar M, Peterson J, Hurenkamp J, Brantjes H, Moerer P, van de Wetering M, Destrée O, Clevers H.

Nature. 1998 Oct 8;395(6702):608-12.

PMID:
9783587
5.

Drosophila Tcf and Groucho interact to repress Wingless signalling activity.

Cavallo RA, Cox RT, Moline MM, Roose J, Polevoy GA, Clevers H, Peifer M, Bejsovec A.

Nature. 1998 Oct 8;395(6702):604-8.

PMID:
9783586
6.

Identification of c-MYC as a target of the APC pathway.

He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW.

Science. 1998 Sep 4;281(5382):1509-12.

7.

c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry.

Prall OW, Rogan EM, Musgrove EA, Watts CK, Sutherland RL.

Mol Cell Biol. 1998 Aug;18(8):4499-508.

8.

Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin.

Simcha I, Shtutman M, Salomon D, Zhurinsky J, Sadot E, Geiger B, Ben-Ze'ev A.

J Cell Biol. 1998 Jun 15;141(6):1433-48.

9.

Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta.

Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P.

Curr Biol. 1998 May 7;8(10):573-81.

10.

Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1.

Watanabe G, Albanese C, Lee RJ, Reutens A, Vairo G, Henglein B, Pestell RG.

Mol Cell Biol. 1998 Jun;18(6):3212-22.

11.

Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta.

Behrens J, Jerchow BA, Würtele M, Grimm J, Asbrand C, Wirtz R, Kühl M, Wedlich D, Birchmeier W.

Science. 1998 Apr 24;280(5363):596-9.

12.

Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways.

Novak A, Hsu SC, Leung-Hagesteijn C, Radeva G, Papkoff J, Montesano R, Roskelley C, Grosschedl R, Dedhar S.

Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4374-9.

13.

Beta-catenin: a key mediator of Wnt signaling.

Willert K, Nusse R.

Curr Opin Genet Dev. 1998 Feb;8(1):95-102. Review.

PMID:
9529612
15.

The role of beta-catenin in cell adhesion, signal transduction, and cancer.

Bullions LC, Levine AJ.

Curr Opin Oncol. 1998 Jan;10(1):81-7. Review.

PMID:
9466489
16.

Regulation of beta-catenin levels and localization by overexpression of plakoglobin and inhibition of the ubiquitin-proteasome system.

Salomon D, Sacco PA, Roy SG, Simcha I, Johnson KR, Wheelock MJ, Ben-Ze'ev A.

J Cell Biol. 1997 Dec 1;139(5):1325-35.

17.

Armadillo and dTCF: a marriage made in the nucleus.

Cavallo R, Rubenstein D, Peifer M.

Curr Opin Genet Dev. 1997 Aug;7(4):459-66. Review.

PMID:
9309175
18.

beta-catenin is a target for the ubiquitin-proteasome pathway.

Aberle H, Bauer A, Stappert J, Kispert A, Kemler R.

EMBO J. 1997 Jul 1;16(13):3797-804.

19.

Carcinogenesis: a balance between beta-catenin and APC.

Gumbiner BM.

Curr Biol. 1997 Jul 1;7(7):R443-6. Review.

20.

The adenomatous polyposis coli (APC) tumor suppressor.

Polakis P.

Biochim Biophys Acta. 1997 Jun 7;1332(3):F127-47. Review.

PMID:
9196022
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk